Kimberly-Clark Corporation (NASDAQ:KMB) is included among the 7 Best Non-REIT Dividend Stocks to Invest in. Kimberly-Clark Corporation (NASDAQ:KMB) operates globally in personal care, with its ...

Staff report Kimberly-Clark Corp. and Kenvue Inc. announced that the shareholders of both boards voted Thursday to approve ...

Looking ahead, Kimberly-Clark ( KMB) said it expects 2026 organic sales growth to grow in line with or ahead of the weighted ...

Near a 12-year low, Kimberly-Clark may be one of the best deep value stocks for income investors to buy in 2026.

Kimberly-Clark Corp. reported net sales of $4.1 billion for the fourth quarter of 2025 and $16.4 billion for the full year ...

Kimberly-Clark (NASDAQ:KMB) used its fourth-quarter and full-year 2025 business update to emphasize progress under its ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

The Irving-headquartered public company is inching closer to completing its nearly $49 billion purchase of the Tylenol ...

Kimberly-Clark reported a higher profit in its latest quarter just days before shareholders vote on its plan to buy Kenvue, a deal designed to create a global health-and-wellness giant.

Kimberly-Clark (NASDAQ:KMB) is nearing a sale of its Kleenex and tissue businesses outside of North America to Brazilian pulp producer Suzano (NYSE:SUZ) for ~$3.5B, in a deal that could be completed ...

Kimberly-Clark Corp.’s board of directors on Tuesday declared an increase in its regular quarterly dividend to $1.28 per share, up ...

(Reuters) -Kimberly-Clark is nearing a sale of its Kleenex and tissue businesses outside of North America for around $3.5 billion to Brazilian pulpmaker Suzano, the Wall Street Journal reported, ...